ZyVersa Therapeutics, Inc. (ZVSA)

NASDAQ: ZVSA · Real-Time Price · USD

0.7151

+0.0071 (1.00%)

At close: Apr 24, 2025, 4:00 PM

0.7151

0.00 (0.00%)

Pre-market: Apr 25, 2025, 6:24 AM EDT

ZyVersa Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for ZyVersa Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for ZyVersa Therapeutics.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24
Strong Buy	1	1	1	1
Buy	0	0	0	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12 → $240	Strong Buy	Reiterates	$12 → $240	+33,461.74%	Mar 26, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $480 → $240	Strong Buy	Maintains	$480 → $240	+33,461.74%	Mar 12, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $480	Strong Buy	Reiterates	$480	+67,023.48%	Feb 29, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $1,750	Strong Buy	Initiates	$1,750	+244,621.02%	Sep 8, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.25

from -8.48

EPS Next Year

-3.98

from -1.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-187.81	-3.35	-0.62	-1,089.70	-8.48	-1.25	-3.98
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-1.29	-4.10
Avg	-1.25	-3.98
Low	-1.21	-3.82

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.